Home Meetings Upcoming SUFU Needs & Objectives

Educational Needs & Objectives

SUFU 2019 Winter Meeting
February 26 – March 2, 2019
InterContinental Miami Hotel
Miami, Florida

Educational Needs

The SUFU 2019 Winter Meeting will include both a basic and translational research focus as well as a high-level clinical curriculum.  The meeting will be comprised of panel discussions, keynote addresses, and research abstracts on conditions that affect the lower urinary tract and pelvic floor.  This format will be utilized to provide an interactive presentation of state-of the-art knowledge in some of the most active areas in benign urologic research.  The overall objective of the meeting will be to disseminate current knowledge in this field and stimulate advanced thinking to further our understanding of the pathophysiology and treatment of pelvic floor disorders.

Though the conditions that will be discussed are benign, it is well-established that they can have a tremendous negative quality of life impact on patients and their families not to mention the huge economic burden they place on society.  The educational needs of the attendees are based upon the importance of having a global understanding of pelvic floor disorders in order to optimize the care of our patients with these disorders.  The clinical science portion of the meeting will include topics related to male and female incontinence, refractory overactive bladder, neurogenic bladder, recurrent urinary tract infections with appropriate use of antibiotics, nocturia, benign prostatic hypertrophy and its guidelines updates,  the role of urodynamics, transitional medicine, and different approaches to pelvic floor reconstruction.  In addition, practical and important non-clinical topics such as coding, physician burnout, opioid use in our patients, dermatologic disorders of the vulva and the impact of registries in FPMRS will be covered.

Attendees of the SUFU program should be familiar with these conditions and the latest thinking regarding these important clinical and practice-related topics.  The meeting will be designed to encourage and foster interactions and collaboration between clinicians, investigators and basic scientists. Attendees will benefit from dialogue regarding these topics, which will facilitate their ability to provide optimal patient care.

Dr. Scott Earley’s keynote address entitled “TRP Ion Channel Superfamily: Novel Targets for Therapeutic Development” will describe current research designed to elucidate how the transient receptor potential (TRP) superfamily of cation channels contributes to the function of the vasculature, urinary bladder, and other tissue that are of interest to conference attendees. The lecture will present a general overview of the TRP superfamily and will discuss how these channels can be targeted for therapeutic development in specific organ systems. This session will have the potential to significantly improve our understanding of TRP channels in urodynamics.

Dr. Thomas Kessler’s keynote address entitled “Neuro-Urology: From Bench to Bedside” will provide an update on research advances in diagnosis and treatment of neurogenic lower urinary tract dysfunction. The lecture will present an overview of current research in this area and how new knowledge from these investigations is being translated from the laboratory into clinical practice. This session will provide the latest updates in this important area, and dissemination of knowledge from this keynote address will have the potential to significantly improve our understanding of neuro-urology.

Educational Objectives

At the completion of the SUFU 2019 Winter Meeting, attendees will be able to:

  1. Explain the roles of ion channels in detrusor smooth muscle function and bladder pathology.
  2. Describe the roles of the limbic system and the amygdala in modulating urologic pain.
  3. Discuss mitochondrial dysfunction and oxidative stress in bladder health and disease.
  4. Describe the findings from the NIH-funded LURN Research Network to study lower urinary tract symptoms (LUTS)
  5. Discuss the basic science and clinical presentation of central sensitization in interstitial cystitis, chronic prostatitis, and overactive bladder.
  6. Describe the current understanding of the role of TRP channels in physiology/urology.
  7. Describe specific TRP channels that are promising drug targets for the treatment of chronic vascular and urological diseases.
  8. Describe advances in diagnosis and treatment of neurogenic lower urinary tract dysfunction.
  9. Describe advances in translational research in neurogenic lower urinary tract dysfunction.
  10. Discuss the options for optimal antibiotic prophylaxis in the Female Pelvic Medicine and Reconstructive Surgery (FPMRS) patient.
  11. Discuss caveats of treating refractory overactive bladder (OAB), how to counsel patients, and when to consider lead repositioning and use of novel therapies.
  12. Identify the vulvar dermatologic disorders in certain clinical scenarios in FPMRS and how to treat them.
  13. Describe approaches to urologic reconstructive in the setting of the most complex neurogenic and non-neurogenic disorders of the urethra and bladder.
  14. Explain the updated the American Urological Association (AUA) benign prostatic hyperplasia (BPH) guidelines, including the rationale behind the key points of focus and differences from previous versions of it.
  15. Describe the pathophysiology of nocturia and be comfortable with the proper thorough evaluation and treatment of patients with nocturia, taking into consideration the potential contributing factors to their condition.
  16. Discuss the phenomenon of physician burnout, its potential causes, and strategies to combat and address this problem.
  17. Discuss the role and value of urodynamics in the management of patients with post-prostatectomy incontinence, OAB, stress incontinence and prolapse.
  18. Explain the changes brought forth by the evolution of the FPMRS specialty and what might be anticipated in the future.
  19. Explain the variety of options available for treatment of BPH, and the pros, cons, and challenges of each of the newer minimally invasive options.
  20. Discuss the importance of collaborative research in the advancement of FPMRS and the imperative role of a multi-disciplinary team, with each member bringing a different and important perspective to the table.
  21. Explain the proper evaluation and diagnosis of UTIs, preventative strategies based on each individual patient, and appropriate treatment utilizing good stewardship of antibiotics.
  22. Discuss the concept and importance of translational research and how it may impact the field of FPMRS.
  23. Define FPMRS-specific coding in order to be in compliance with proper practice.
  24. Identify the surgical options for apical prolapse, including a variety of vaginal, open abdominal and robotic approaches and be able to discuss the current concepts of vaginal vault suspensions based on new and evolving data.
  25. Discuss the important considerations and the pros and cons of each of a variety of treatment options for neurogenic bladder and the considerations associated with each.
  26. Identify the challenges of the complex interstitial cystitis patient and how various options may be used in the toughest cases.
  27. Explain the challenges with opioid use in the FPMRS patient population and discuss a management plan for patients to limit at risk behaviors.
  28. Describe the use of patient registries and the challenges with their implementation.
  29. Identify the pros and cons of the versions of the Asymptomatic MicroHematuria Guidelines and the different ways one can approach a patient with (AMH)
  30. Identify a management plan for the complex FPMRS patient, their medical issues and how best to prevent complications in them.